“The World Pharmaceutical Anti-Counterfeiting Technologies Market will reach $3.4Bn in 2015”

LONDON - Dec. 9, 2014 - PRLog -- LONDON, UK, 3^rd of December 2014: A new report by visiongain predicts that the world market for pharmaceutical anti-counterfeiting technologies will reach $3.4bn in 2015. This forecast and others appear in Pharmaceutical Anti-counterfeiting Technologies: Market Analysis and Forecasts 2015-2025, published in December 2014. Visiongain is a business information provider based in London, UK.

Visiongain predicts that the pharmaceutical anti-counterfeiting technologies market will grow strongly to 2025. The illicit trade in counterfeit drugs costs the pharmaceutical industry billions of dollars each year. Also, the consumption of counterfeit drugs poses a serious threat to public health. Growth of international free trade and inadequate drug regulation has led to the expansion of trade in counterfeit drugs worldwide. Many countries lack the appropriate legislation governing the manufacture, distribution, export and import of pharma products to deal with this matter effectively. Visiongain believes drug counterfeiting is one of the most pressing challenges facing the pharmaceutical industry. The more-widespread adoption and development of innovative anti-counterfeiting technologies will help to defeat counterfeiting activities.

Wenlu Hu, a pharmaceutical and medical devices industry analyst in visiongain, said: “The pharmaceutical anti-counterfeiting technologies market represents a highly lucrative area with many opportunities for manufacturers in the coming decade. Rising concerns from many pharmaceutical companies to sustain brand loyalty and avoid revenue loss to counterfeiters will stimulate demand for supply chain security, authentication and verification solutions. In addition the newly imposed government legislations on serialisation of drugs across several key national markets including the US and EU will further stimulate growth in this market. Developing countries such as China and India are also becoming sensitised about the extent and major health consequences of the problem and are implementing strategies to increase the safety of their internal pharmaceutical supply chains.”

“The implementation of anti-counterfeit technologies remains the most prominent preventive measure against counterfeiters. Visiongain believes that track-and-trace technology; in particular RFID will be a key area of market growth. However such technology is limited in its ability to authenticate medicines inside the packaging and thus other ways of authentication must be integrated into the supply chain. Furthermore the successful introduction of worldwide industry standards, as well as cooperation between regulatory authorities and manufacturers will be essential to securing the supply chain”

Visiongain’s brand new 242-page report provides trends and revenue forecasts to 2025 for the world market and 8 key regional markets, including US, EU5 (Germany, France, UK, Italy, Spain) as a group, Japan, China, India, Brazil, Russia and Mexico. It also forecasts the leading technology submarkets: barcodes, RFID, holograms/OVD, taggants and other pharma anti-counterfeiting technologies from 2015 to 2025.

In addition the report profiles 16 leading companies and contains 6 exclusive interviews with industry experts from Zebra Technology, Authentix, Applied DNA Sciences, NovaVision, AlpVision and so forth, regarding current market trends, upcoming anti-counterfeiting technologies and future opportunities.

The report also discusses commercial news, drivers and restraints in each country and submarkets, as well as qualitative SWOT, STEP and market attractiveness analysis to understand the competitive landscape within the pharmaceutical anti-counterfeiting market.

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis and Forecasts 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare.

Email: Sara Peerun on sara.peerun@visiongainglobal.com

Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.